TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 106 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $462,357 | +439.3% | 161,100 | +232.6% | 0.00% | +200.0% |
Q4 2023 | $85,728 | -5.9% | 48,434 | +20.2% | 0.00% | 0.0% |
Q4 2022 | $91,080 | -58.6% | 40,301 | +19.6% | 0.00% | -50.0% |
Q1 2022 | $220,000 | -3.9% | 33,694 | +71.6% | 0.00% | 0.0% |
Q4 2021 | $229,000 | +94.1% | 19,635 | +340.9% | 0.00% | 0.0% |
Q4 2020 | $118,000 | – | 4,453 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,330,937 | $5,221,299 | 4.40% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,700,000 | $8,288,000 | 1.68% |
Octagon Capital Advisors LP | 4,572,222 | $10,241,777 | 1.61% |
VR Adviser, LLC | 9,000,000 | $20,160,000 | 1.28% |
Ghost Tree Capital, LLC | 1,250,000 | $2,800,000 | 0.88% |
RTW INVESTMENTS, LP | 18,800,299 | $42,112,670 | 0.65% |
Diametric Capital, LP | 512,361 | $1,147,688 | 0.62% |
Quantum Private Wealth, LLC | 730,520 | $1,636,365 | 0.58% |
Avoro Capital Advisors LLC | 18,650,000 | $41,776,000 | 0.56% |
Sands Capital Ventures, LLC | 724,873 | $1,623,716 | 0.54% |